Thomas W Keenan

Title: The Innovative Contributions of Thomas W. Keenan

Introduction

Thomas W. Keenan is a notable inventor based in West Lafayette, Indiana. He has made significant contributions to the field of cancer detection through his innovative research and patented methods. His work focuses on the analysis of glycolipids in serum, which has implications for early cancer detection.

Latest Patents

Keenan holds a patent for a method titled "Cancer detection by serum analysis of glycolipids." This method reveals that serum levels of sialic acid-containing glycolipids are elevated 1.5 to 3 fold in humans and experimental animals. The procedure allows for the estimation of ganglioside content using as little as 0.5 ml of serum or plasma. This innovative approach enables cancer detection based on the analysis of a single biochemical parameter, applicable to a wide range of human and animal tumor types.

Career Highlights

Keenan is associated with the Purdue Research Foundation, where he continues to advance his research in cancer detection. His work has garnered attention for its potential to improve diagnostic methods in oncology.

Collaborations

Throughout his career, Thomas W. Keenan has collaborated with esteemed colleagues, including D. James Morre and Thomas M. Kloppel. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer detection.

Conclusion

Thomas W. Keenan's contributions to cancer detection through serum analysis of glycolipids highlight the importance of innovation in medical research. His work not only advances scientific understanding but also has the potential to save lives through early detection methods.